Home
Conditions
Neoplastic Processes

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies

Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07229313

Conditions: Adnexal Diseases, Advance Solid Tumors, Breast Diseases, +59 more
Locations: Kivu Trial Site Santa Monica, California, United States

Kivu Trial Site Camperdown, New South Wales, Australia

Kivu Trial Site Sydney, New South Wales, Australia

Kivu Trial Site Brisbane, Queensland, Australia

View Trial Details

Recruiting

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

NCT04693377

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +66 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

NCT03010150

Conditions: Carcinoma, Carcinoma of Unknown Primary, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +53 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients

NCT05821556

Conditions: Adenocarcinoma of the Pancreas, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale Naples, Italy

Università vita e Salute, IRCCS San Raffaele Milan, Milano, Italy

Università Cattolica Del Sacro Cuore, IRCCS Fondazione Policlinico Universitario Gemelli - Medical Oncology, Roma, Italia Roma, Italy

University of Verona Hospital Trust Verona, Italy

View Trial Details

Recruiting

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

NCT05576974

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +13 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Recruiting

New MRI Biomarkers in Head and Neck Cancers

NCT03483337

Conditions: Disease Attributes, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions: ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Florida Cancer Specialists Lake Mary, Florida, United States

Dartmouth Hitchcock Lebanon, New Hampshire, United States

Brown University Health Cancer Institute Providence, Rhode Island, United States

View Trial Details

Recruiting

SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial

NCT05222620

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +11 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States

Mayo Clinic Health Systems-Mankato Mankato, Minnesota, United States

View Trial Details

Recruiting

Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

NCT07522762

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointenstinal Stromal Tumor (GIST), +11 more
Locations: Antoni van Leeuwenhoek Amsterdam, North Holland, Netherlands

View Trial Details

Recruiting

Biomarkers to Detect Endocrine Therapy Resistance

NCT06067503

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +17 more
Locations: UW Carbone Cancer Center Madison, Wisconsin, United States

View Trial Details

Neoplastic Processes

Neoplastic Processes trial results

Related conditions